跳至主要内容
临床试验/EUCTR2007-007474-33-AT
EUCTR2007-007474-33-AT进行中(未招募)1 期

Prospective, placebo-controlled trial of vitamin D supplementation in patients with low-levels of 25-OH vitamin D to evaluate changes in markers of cardiovascular risk

Dr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin0 个研究点目标入组 100 人开始时间: 2008年4月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 25(OH)D level <20 ng/ml
  • age between 45 and 75 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Heart failure > NYHA II
  • previous cardiovascular events
  • Serum Creatinine > 1.5 mg/dl
  • AST / ALT > 3x ULN
  • diabetes mellitus
  • uncontrolled hypertension (RR>160/100, either or)
  • new onset of statins or ACE-I or ARBs (within the last 2 month)
  • hypercalcaemia
  • urolithiasis
  • major psychiatric disorder

研究者

发起方
Dr. Harald Dobnig, Medizinische Univ. Klinik Graz, Abteilung für Endokrinologie und Nuklearmedizin

相似试验

Prospective, placebo-controlled trial of vitamin D... | 临床试验